Last updated: 22 November 2021 at 9:12am EST

Adam M Veness Net Worth




The estimated Net Worth of Adam M Veness is at least $5.08 Milion dollars as of 9 November 2021. Adam Veness owns over 4,500 units of Acceleron Pharma Inc stock worth over $4,186,861 and over the last 5 years Adam sold XLRN stock worth over $888,634.

Adam Veness XLRN stock SEC Form 4 insiders trading

Adam has made over 10 trades of the Acceleron Pharma Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Adam exercised 4,500 units of XLRN stock worth $132,165 on 9 November 2021.

The largest trade Adam's ever made was exercising 6,650 units of Acceleron Pharma Inc stock on 21 September 2021 worth over $216,657. On average, Adam trades about 1,904 units every 56 days since 2019. As of 9 November 2021 Adam still owns at least 23,423 units of Acceleron Pharma Inc stock.

You can see the complete history of Adam Veness stock trades at the bottom of the page.



Insiders trading at Acceleron Pharma Inc

Over the last 11 years, insiders at Acceleron Pharma Inc have traded over $211,038,855 worth of Acceleron Pharma Inc stock and bought 4,435,573 units worth $172,392,007 . The most active insiders traders include Corp /De/ Celgene, Richard F Pops oraz Anthony B Evnin. On average, Acceleron Pharma Inc executives and independent directors trade stock every 10 days with the average trade being worth of $7,646,210. The most recent stock trade was executed by Adam M Veness on 9 November 2021, trading 4,500 units of XLRN stock currently worth $132,165.



What does Acceleron Pharma Inc do?

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.



What does Acceleron Pharma Inc's logo look like?

Acceleron Pharma Inc logo

Complete history of Adam Veness stock trades at Acceleron Pharma Inc

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
9 Nov 2021 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Opcja Ćwiczenie 4,500 $29.37 $132,165
9 Nov 2021
23,423
21 Sep 2021 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Opcja Ćwiczenie 6,650 $32.58 $216,657
21 Sep 2021
25,573
7 Sep 2021 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Sprzedaż 1,413 $130.00 $183,690
7 Sep 2021
18,923
4 Jan 2021 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Sprzedaż 2,056 $122.56 $251,983
4 Jan 2021
16,163
8 Sep 2020 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Sprzedaż 2,000 $89.50 $179,000
8 Sep 2020
19,161
8 Apr 2020 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Opcja Ćwiczenie 6,000 $27.97 $167,820
8 Apr 2020
27,161
2 Jan 2020 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Sprzedaż 1,309 $51.76 $67,754
2 Jan 2020
14,792
10 Sep 2019 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Sprzedaż 824 $45.20 $37,245
10 Sep 2019
16,101
9 Aug 2019 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Sprzedaż 3,268 $45.00 $147,060
9 Aug 2019
16,925
16 Jul 2019 Adam M Veness
SVP, Główny radca prawny oraz Sec.
Sprzedaż 538 $40.71 $21,902
16 Jul 2019
20,193


Acceleron Pharma Inc executives and stock owners

Acceleron Pharma Inc executives and other stock owners filed with the SEC include: